Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Alvogen Korea

Clinical trials sponsored by Alvogen Korea, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New Once-Daily pill aims to tame ADHD symptoms in korean youth Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

New Once-Daily pill aims to tame ADHD symptoms in korean youth

Disease control Not yet recruiting

This phase 3 trial tests whether viloxazine extended-release capsules, taken once daily, can safely reduce ADHD symptoms in Korean children and adolescents aged 6 to 17. Participants receive either the drug or a placebo for 8 weeks, with doses adjusted based on response. The stud…

Phase 3 • Sponsor: Alvogen Korea • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC